|
FY2025
12 months to Dec 27, 2025
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Gross profit | ||||
| Research and development, net | ||||
| Sales and marketing | ||||
| General and administrative | ||||
| Goodwill impairment | ||||
| Total operating expenses | ||||
| Operating income (loss) | ||||
| Interest income with related party | ||||
| Financial income (expense), net | ||||
| Income (loss) before income taxes | ||||
| Benefit (provision) for income taxes | ||||
| Net income (loss) | ||||
| Earnings (loss) per share attributed to Class A and Class B stockholders: | ||||
| Basic | ||||
| Diluted | ||||
| Weighted-average number of shares used in computation of earnings (loss) per share attributed to Class A and Class B stockholders (in millions): | ||||
| Basic | ||||
| Diluted | ||||
| Other comprehensive income (loss), net of tax | ||||
| TOTAL COMPREHENSIVE INCOME (LOSS) | ||||
Loading...
